Beijing Science Sun Pharmaceutical Co Ltd (300485) — Cash Flow-to-Debt Ratio
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥28.68 Million could theoretically repay 0% of its total liabilities (CN¥171.26 Million) in one year. See free cash flow generation of Beijing Science Sun Pharmaceutical Co Lt to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Beijing Science Sun Pharmaceutical Co Ltd across 14 annual periods. Also explore net asset momentum of Beijing Science Sun Pharmaceutical Co Lt to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Beijing Science Sun Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 300485 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.82x | CN¥135.97 Million | CN¥166.48 Million | ▲ +495.3% |
| 2023 | 0.14x | CN¥21.21 Million | CN¥154.61 Million | ▼ -80.5% |
| 2022 | 0.70x | CN¥110.43 Million | CN¥157.10 Million | ▼ -54.5% |
| 2021 | 1.55x | CN¥183.30 Million | CN¥118.54 Million | ▼ -17.3% |
| 2020 | 1.87x | CN¥263.73 Million | CN¥141.13 Million | ▲ +2.1% |
| 2019 | 1.83x | CN¥172.52 Million | CN¥94.26 Million | ▲ +156.2% |
| 2018 | 0.71x | CN¥146.52 Million | CN¥205.07 Million | ▼ -11.6% |
| 2017 | 0.81x | CN¥108.21 Million | CN¥133.91 Million | ▼ -55.0% |
| 2016 | 1.79x | CN¥212.89 Million | CN¥118.63 Million | ▼ -34.3% |
| 2015 | 2.73x | CN¥169.36 Million | CN¥62.00 Million | ▼ -8.6% |
| 2014 | 2.99x | CN¥214.23 Million | CN¥71.71 Million | ▼ -28.2% |
| 2013 | 4.16x | CN¥196.82 Million | CN¥47.33 Million | ▼ -3.7% |
| 2012 | 4.32x | CN¥151.93 Million | CN¥35.18 Million | ▲ +81.6% |
| 2011 | 2.38x | CN¥77.06 Million | CN¥32.39 Million | — |